Payam Nahid

13.4k total citations · 2 hit papers
102 papers, 4.6k citations indexed

About

Payam Nahid is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Payam Nahid has authored 102 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 88 papers in Infectious Diseases, 60 papers in Epidemiology and 35 papers in Surgery. Recurrent topics in Payam Nahid's work include Tuberculosis Research and Epidemiology (87 papers), Mycobacterium research and diagnosis (38 papers) and Infectious Diseases and Tuberculosis (26 papers). Payam Nahid is often cited by papers focused on Tuberculosis Research and Epidemiology (87 papers), Mycobacterium research and diagnosis (38 papers) and Infectious Diseases and Tuberculosis (26 papers). Payam Nahid collaborates with scholars based in United States, Uganda and United Kingdom. Payam Nahid's co-authors include Alimuddin Zumla, Stewart T. Cole, Philip C. Hopewell, Robert M. Jasmer, Leah G. Jarlsberg, Dennis Osmond, L. Masae Kawamura, John L. Johnson, Karen R Steingart and Charles L. Daley and has published in prestigious journals such as New England Journal of Medicine, Nature Medicine and Nature Communications.

In The Last Decade

Payam Nahid

94 papers receiving 4.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Advances in the development of new tuberculosis drugs and treatment regimens

2013 690 citations Payam Nahid et al. profile →
Adherence interventions and outcomes of tuberculosis treatment: A systematic review and meta-analysis of trials and observational studies

2018 276 citations Narges Alipanah, Leah G. Jarlsberg et al. PLoS Medicine profile →

Peers

Payam Nahid

EPIDE

SURGE

IMMUN

Peter Mwaba Zambia

Rosella Centis Italy

Jennifer Furin United States

Matthew Bates United Kingdom

Roxana Rustomjee South Africa

Payam Tabarsi Iran

Matteo Zignol Switzerland

Michael G. Ison United States

Jeremiah Chakaya Kenya

Neel R. Gandhi United States

Peter Mwaba Zambia

Payam Nahid

4.4k ×1.3

3.4k ×1.4

EPIDE

1.5k ×1.2

SURGE

847 ×0.9

338 ×1.0

IMMUN

Citations per year, relative to Payam Nahid Payam Nahid (= 1×) peers Peter Mwaba

Countries citing papers authored by Payam Nahid

Since Specialization

Citations

This map shows the geographic impact of Payam Nahid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Payam Nahid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Payam Nahid more than expected).

Fields of papers citing papers by Payam Nahid

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Payam Nahid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Payam Nahid. The network helps show where Payam Nahid may publish in the future.

Co-authorship network of co-authors of Payam Nahid

This figure shows the co-authorship network connecting the top 25 collaborators of Payam Nahid. A scholar is included among the top collaborators of Payam Nahid based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Payam Nahid. Payam Nahid is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chow, Felicia C., Edward J. Farrell, Margaret D. Wilson, et al.. (2025). Safety and Tolerability of a Short Course of Linezolid for the Treatment of Predominantly Moderate to Severe Tuberculous Meningitis in Adults With Human Immunodeficiency Virus. The Journal of Infectious Diseases. 231(6). e1034–e1044. 2 indexed citations

Nalugwa, Talemwa, Deepa Shankar, Alfred Andama, et al.. (2025). Preferences for tuberculosis diagnostic test features among people tested for tuberculosis: a multicountry discrete choice experiment. 1(3). 100012–100012.

Crowder, Rebecca, Alfred Andama, Devasahayam Jesudas Christopher, et al.. (2024). Diagnostic Accuracy of Tuberculosis Screening Tests in a Prospective Multinational Cohort: Chest Radiography With Computer-Aided Detection, Xpert Tuberculosis Host Response, and C-Reactive Protein. Clinical Infectious Diseases. 82(2). e239–e247. 1 indexed citations

Jain, Sonal, Tobias Broger, Chris Isaacs, et al.. (2024). Innovative COVID-19 Point-of-Care Diagnostics Suitable for Tuberculosis Diagnosis: A Scoping Review. Journal of Clinical Medicine. 13(19). 5894–5894.

Andama, Alfred, Grant R. Whitman, Rebecca Crowder, et al.. (2022). Accuracy of Tongue Swab Testing Using Xpert MTB-RIF Ultra for Tuberculosis Diagnosis. Journal of Clinical Microbiology. 60(7). e0042122–e0042122. 38 indexed citations

Bauman, Allison, Karen Rossmassler, Martin I. Voskuil, et al.. (2022). Combination of Mycobacterium tuberculosis RS Ratio and CFU Improves the Ability of Murine Efficacy Experiments to Distinguish between Drug Treatments. Antimicrobial Agents and Chemotherapy. 66(4). e0231021–e0231021. 12 indexed citations

Imperial, Marjorie Z., Patrick Phillips, Payam Nahid, & Radojka M. Savić. (2021). Precision-Enhancing Risk Stratification Tools for Selecting Optimal Treatment Durations in Tuberculosis Clinical Trials. American Journal of Respiratory and Critical Care Medicine. 204(9). 1086–1096. 26 indexed citations

Lienhardt, Christian, Andrew Nunn, Richard E. Chaisson, et al.. (2020). Advances in clinical trial design: Weaving tomorrow’s TB treatments. PLoS Medicine. 17(2). e1003059–e1003059. 14 indexed citations

Alipanah, Narges, Priya B. Shete, Nguyen Viet Nhung, et al.. (2019). Feasibility of Direct Sputum Molecular Testing for Drug Resistance as Part of Tuberculosis Clinical Trials Eligibility Screening. Diagnostics. 9(2). 56–56. 2 indexed citations

10.

Phillips, Patrick, Carole D. Mitnick, James D. Neaton, et al.. (2019). Keeping phase III tuberculosis trials relevant: Adapting to a rapidly changing landscape. PLoS Medicine. 16(3). e1002767–e1002767. 15 indexed citations

11.

Lienhardt, Christian, et al.. (2019). Development of new TB regimens: Harmonizing trial design, product registration requirements, and public health guidance. PLoS Medicine. 16(9). e1002915–e1002915. 11 indexed citations

12.

Kendall, Emily A., Sourya Shrestha, Ted Cohen, et al.. (2017). Priority-Setting for Novel Drug Regimens to Treat Tuberculosis: An Epidemiologic Model. PLoS Medicine. 14(1). e1002202–e1002202. 19 indexed citations

13.

Cattamanchi, Adithya, John Metcalfe, Denise M. Connor, et al.. (2016). Tuberculosis progression rates in U.S. Immigrants following screening with interferon-gamma release assays. BMC Public Health. 16(1). 875–875. 11 indexed citations

14.

Dorman, Susan E., Radojka M. Savić, Stefan Goldberg, et al.. (2014). Daily Rifapentine for Treatment of Pulmonary Tuberculosis. A Randomized, Dose-Ranging Trial. American Journal of Respiratory and Critical Care Medicine. 191(3). 333–343. 76 indexed citations

15.

Menzies, Dick & Payam Nahid. (2013). Update in Tuberculosis and Nontuberculous Mycobacterial Disease 2012. American Journal of Respiratory and Critical Care Medicine. 188(8). 923–927. 26 indexed citations

16.

Nahid, Payam & Dick Menzies. (2012). Update in Tuberculosis and Nontuberculous Mycobacterial Disease 2011. American Journal of Respiratory and Critical Care Medicine. 185(12). 1266–1270. 13 indexed citations

17.

Nahid, Payam, Jussi Saukkonen, William R. Mac Kenzie, et al.. (2011). Tuberculosis Biomarker and Surrogate Endpoint Research Roadmap. American Journal of Respiratory and Critical Care Medicine. 184(8). 972–979. 41 indexed citations

18.

Nahid, Payam, Leah G. Jarlsberg, Bouke C. de Jong, et al.. (2011). Factors associated with mortality in patients with drug-susceptible pulmonary tuberculosis. BMC Infectious Diseases. 11(1). 1–1. 245 indexed citations

19.

Metcalfe, John, Adithya Cattamanchi, Eric Vittinghoff, et al.. (2009). Evaluation of Quantitative IFN-γ Response for Risk Stratification of Active Tuberculosis Suspects. American Journal of Respiratory and Critical Care Medicine. 181(1). 87–93. 30 indexed citations

20.

Nahid, Payam, Leah C. Gonzalez, Bouke C. de Jong, et al.. (2007). Treatment Outcomes of Patients with HIV and Tuberculosis. American Journal of Respiratory and Critical Care Medicine. 175(11). 1199–1206. 99 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact